ATAI vs. DFTX
ATAI (Atai Life Sciences N.V.) and DFTX (Definium Therapeutics, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, ATAI returned 29.14%/yr vs 87.91%/yr for DFTX. At a 0.44 correlation, their price movements are largely independent.
Performance
ATAI vs. DFTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATAI achieves a -4.16% return, which is significantly lower than DFTX's 84.84% return.
ATAI
- 1D
- 3.16%
- 1M
- -2.97%
- YTD
- -4.16%
- 6M
- -8.62%
- 1Y
- 85.78%
- 3Y*
- 29.14%
- 5Y*
- —
- 10Y*
- —
DFTX
- 1D
- 2.65%
- 1M
- 15.93%
- YTD
- 84.84%
- 6M
- 97.21%
- 1Y
- 245.19%
- 3Y*
- 87.91%
- 5Y*
- —
- 10Y*
- —
ATAI vs. DFTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ATAI Atai Life Sciences N.V. | -4.16% | 207.52% | -5.67% | -46.99% | -38.28% |
DFTX Definium Therapeutics, Inc | 84.84% | 92.39% | 90.16% | 66.36% | -78.74% |
Correlation
The correlation between ATAI and DFTX is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.52 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (All Time) Calculated using the full available price history since Jul 11, 2022 | 0.44 |
The correlation between ATAI and DFTX has been stable across timeframes, ranging from 0.44 to 0.52 - a consistent structural relationship.
Fundamentals
ATAI:
$1.40B
DFTX:
$2.69B
ATAI:
-$2.67
DFTX:
-$2.57
ATAI:
7.05
DFTX:
9.66
ATAI:
$3.49M
DFTX:
$0.00
ATAI:
$3.49M
DFTX:
$0.00
ATAI:
-$663.38M
DFTX:
-$206.36M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATAI vs. DFTX — Risk / Return Rank
ATAI
DFTX
ATAI vs. DFTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Atai Life Sciences N.V. (ATAI) and Definium Therapeutics, Inc (DFTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ATAI | DFTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.91 | ||
| Sortino ratioReturn per unit of downside risk | -2.05 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.46 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 1.67 | 9.71 | -8.04 |
| Martin ratioReturn relative to average drawdown | 2.66 | 30.51 | -27.85 |
Loading charts...
Drawdowns
ATAI vs. DFTX - Drawdown Comparison
The maximum ATAI drawdown since its inception was -95.05%, which is greater than DFTX's maximum drawdown of -86.01%. Use the drawdown chart below to compare losses from any high point for ATAI and DFTX.
Loading charts...
Drawdown Indicators
| ATAI | DFTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.05% | -86.01% | -9.04% |
Max Drawdown (1Y)Largest decline over 1 year | -48.06% | -24.79% | -23.27% |
Max Drawdown (3Y)Largest decline over 3 years | -59.23% | -58.38% | -0.85% |
Current DrawdownCurrent decline from peak | -81.33% | 0.00% | -81.33% |
Average DrawdownAverage peak-to-trough decline | -80.78% | -51.22% | -29.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.10% | 7.93% | +22.17% |
Volatility
ATAI vs. DFTX - Volatility Comparison
Atai Life Sciences N.V. (ATAI) has a higher volatility of 20.22% compared to Definium Therapeutics, Inc (DFTX) at 15.21%. This indicates that ATAI's price experiences larger fluctuations and is considered to be riskier than DFTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATAI | DFTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.22% | 15.21% | +5.01% |
Volatility (6M)Calculated over the trailing 6-month period | 50.17% | 38.79% | +11.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 81.21% | 61.83% | +19.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.71% | 83.94% | -0.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.71% | 83.94% | -0.23% |
Dividends
ATAI vs. DFTX - Dividend Comparison
Neither ATAI nor DFTX has paid dividends to shareholders.
Financials
ATAI vs. DFTX - Financials Comparison
This section allows you to compare key financial metrics between Atai Life Sciences N.V. and Definium Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATAI and DFTX have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATAI has higher volatility (20.22%) compared to DFTX (15.21%). In terms of maximum drawdown, ATAI dropped -95.05% vs DFTX's -86.01%.
DFTX currently has the higher Sharpe Ratio (3.89 vs 0.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATAI and DFTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer